EW: Dhuwit awis perusahaan edwards.com

Edwards Lifesciences (EW) - logo korporat

The current cash balance of Edwards Lifesciences (EW), where this figure equals 4.69, correlates with the implementation of minimally invasive valves and regulatory support. Export barriers and logistical complexities in Asia limit the global sales reach of Edwards Lifesciences (EW). Business stability is bolstered by the loyalty of elite cardiac engineers, who are retained through generous bonuses. This chart's dynamics help assess the company's solvency and profitability risks.

EW - Cadangan dhuwit perusahaan Edwards Lifesciences Corp ing rentang 04.07.2022 - 21.11.2026

Rincian analitis perusahaan Edwards Lifesciences

- nilai saham lan prakiraan konsensus rega:
Analisis dhasar perusahaan:EW Edwards Lifesciences Corp
Sampel barang edwards.com

This metric measures the business's net liquidity, excluding accounts receivable to assess the company's actual ability to meet obligations instantaneously. Investors utilize this metric to analyze the balance between financial stability and capital efficiency. By examining the cash reserves chart, one can evaluate the funding pace for Edwards Lifesciences plant modernizations and the implementation of robotic control systems. Sufficient funding ensures the seamless expansion of production lines without excessive credit pressure.

Analisis pesaing Edwards Lifesciences

Volume dana dhuwit perusahaan BSX|Volume dana dhuwit perusahaan resmed.com (RMD)|Volume dana dhuwit perusahaan PODD (insulet.com)|Zimmer Biomet Holdings Inc - Dana dhuwit perusahaan|COO: Dhuwit awis perusahaan|ALGN: Dana dhuwit perusahaan|GMED (Globus Medical, Inc.) - Dhuwit awis perusahaan|TransMedics Organ Care System - Sisa dhuwit perusahaan|ATEC (Alphatec Corp) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan CryoLife AORT|Dana dhuwit perusahaan Enovis Corp (ENOV)|Integra LifeSciences (IART) - Posisi dhuwit perusahaan|Establishment Labs Inc - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Beta Bionics Inc BBNX|IRADIMED Corp - Volume dana dhuwit perusahaan|Aset likuid perusahaan Embecta Corp EMBC|Tandem Diabetes Care, Inc. (TNDM) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan AXGN (Axogen Surgical)|Dana dhuwit perusahaan si-bone.com|Dhuwit awis perusahaan Orthofix Medical Inc. (OFIX)|Dana dhuwit perusahaan Bioventus Corp (BVS)|KIDS - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Treace Medical Concepts TMCI|SRTA: Dhuwit awis lan setara dhuwit awis perusahaan|CARL: Dhuwit awis perusahaan|rxsight.com - Gunggung dana dhuwit perusahaan|CLPT: Volume dana dhuwit perusahaan|STXS - Aset likuid perusahaan|STIM (neurostar.com) - Volume dana dhuwit perusahaan|Sight Sciences, Inc (SGHT) - Aset likuid perusahaan|Volume dana dhuwit perusahaan OBIO|Aset likuid perusahaan Anika Therapeutics Inc.|Dana dhuwit perusahaan InspireMD, Inc. NSPR|Sisa dhuwit perusahaan ZJYL|VANI - Dana dhuwit perusahaan|Xtant Medical Holdings, Inc. - Gunggung dana dhuwit perusahaan|NeuroOne (NMTC) - Dana dhuwit perusahaan|Modular Med (MODD) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Myomo, Inc|Dhuwit awis perusahaan Envoy Medical (COCH)|Volume dana dhuwit perusahaan VVOS|NVNO (enVVeno Corp) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan SINT (Sintx Technologies)|TNON: Dhuwit awis lan setara dhuwit awis perusahaan|Lifeward - Volume dana dhuwit perusahaan|Sisa dhuwit perusahaan AMIX (Autonomix Medical)|IVF: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bone Biologics Corporation BBLG|Dhuwit awis perusahaan AXNX|BIOLASE, Inc. (BIOL) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)